De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Mebuki Financial GroupInc Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Mebuki Financial GroupInc heeft totale activa van ¥21,483.7B en een totaal eigen vermogen van ¥967.4B. De totale deposito's bedragen ¥17,966.3B en de totale leningen bedragen ¥12,627.1B leveren een netto rentemarge op van 0.8%. Er is onvoldoende voorziening voor slechte leningen, die momenteel 1.5% van de totale leningen bedragen. Contant geld en kortetermijninvesteringen zijn ¥3,939.7B.

Belangrijke informatie

22.2x

Verhouding activa / eigen vermogen

0.8%

Nettorentemarge

Totaal deposito's	JP¥17.97t
Verhouding leningen/deposito's	Passend
Slechte leningen	1.5%
Voorziening voor dubieuze leningen	Laag
Huidige ratio	Laag
Geldmiddelen en kasequivalenten	JP¥3.94t

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Mebuki Financial GroupInc's (TSE:7167) Dividend Will Be Increased To ¥7.00

Sep 25

Mebuki Financial GroupInc (TSE:7167) Is Paying Out A Larger Dividend Than Last Year

Aug 09

Mebuki Financial GroupInc's (TSE:7167) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 26

Mebuki Financial GroupInc's (TSE:7167) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 11

Mebuki Financial GroupInc's (TSE:7167) Dividend Will Be ¥6.00

Feb 26

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse financiële instellingen

Activa niveau: De Vermogen/vermogensverhouding ( 22.2 x) 7167 is zeer hoog.

Voorziening voor slechte leningen: 7167 heeft een lage voorziening voor slechte leningen ( 44 %).

Laag risico verplichtingen: 88% van de verplichtingen van 7167 bestaan voornamelijk uit laag risico financieringsbronnen.

Leenniveau: 7167 heeft een passend niveau van Leningen/activa-ratio ( 59% ).

Laag risico deposito's: De Leningen-depositoverhouding ( 70% ) van 7167 } is passend.

Niveau van slechte leningen: 7167 heeft een passend niveau van slechte leningen ( 1.5 %).

Mebuki Financial GroupInc Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Mebuki Financial GroupInc's (TSE:7167) Dividend Will Be Increased To ¥7.00

Mebuki Financial Group,Inc. to Report Q2, 2025 Results on Nov 11, 2024

Upcoming dividend of JP¥7.00 per share

Mebuki Financial GroupInc (TSE:7167) Is Paying Out A Larger Dividend Than Last Year

Investor sentiment deteriorates as stock falls 23%

New minor risk - Share price stability

Mebuki Financial GroupInc's (TSE:7167) Shareholders Will Receive A Bigger Dividend Than Last Year

Mebuki Financial GroupInc's (TSE:7167) Shareholders Will Receive A Bigger Dividend Than Last Year

Final dividend of JP¥7.00 announced

Mebuki Financial Group,Inc. to Report Q1, 2025 Results on Aug 05, 2024

Price target increased by 13% to JP¥650

Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Mebuki Financial Group,Inc., Annual General Meeting, Jun 26, 2024

Mebuki Financial Group,Inc. (TSE:7167) announces an Equity Buyback for 20,000,000 shares, representing 1.97% for ¥10,000 million.

Price target increased by 12% to JP¥518

Mebuki Financial Group,Inc. to Report Fiscal Year 2024 Results on May 10, 2024

Upcoming dividend of JP¥6.00 per share

Mebuki Financial GroupInc's (TSE:7167) Dividend Will Be ¥6.00

Third quarter 2024 earnings released: EPS: JP¥8.56 (vs JP¥4.52 in 3Q 2023)

Mebuki Financial Group,Inc. to Report Q3, 2024 Results on Feb 07, 2024

Mebuki Financial Group, Inc. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 4, 2023 and Provides Dividend Guidance for the Full Year Ending March 31, 2024

Mebuki Financial Group, Inc. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 4, 2023 and Provides Dividend Guidance for the Full Year Ending March 31, 2024

Second quarter 2024 earnings released: EPS: JP¥7.55 (vs JP¥10.72 in 2Q 2023)

Mebuki Financial Group,Inc. to Report Q2, 2024 Results on Nov 10, 2023

Upcoming dividend of JP¥5.50 per share at 2.6% yield

Price target increased by 9.0% to JP¥423

Price target increased by 7.8% to JP¥413

Price target increased by 7.6% to JP¥388

First quarter 2024 earnings released: EPS: JP¥14.66 (vs JP¥14.22 in 1Q 2023)

Consensus revenue estimates increase by 26%, EPS downgraded

Mebuki Financial Group,Inc. to Report Q1, 2024 Results on Aug 04, 2023

Consensus EPS estimates fall by 12%

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Mebuki Financial Group,Inc. (TSE:7167) announces an Equity Buyback for 35,000,000 shares, representing 3.29% for ¥10,000 million.

Mebuki Financial Group,Inc., Annual General Meeting, Jun 22, 2023

Upcoming dividend of JP¥5.50 per share at 3.4% yield

Mebuki Financial Group,Inc. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

Mebuki Financial Group,Inc. Provides Consolidated Earnings Forecasts for Fiscal Year 2022 Ending March 31, 2023

Third quarter 2023 earnings released: EPS: JP¥4.52 (vs JP¥12.55 in 3Q 2022)

Price target increased to JP¥337

Mebuki Financial Group,Inc. to Report Q3, 2023 Results on Feb 06, 2023

Consensus forecasts updated

Second quarter 2023 earnings released: EPS: JP¥10.72 (vs JP¥5.37 in 2Q 2022)

Second quarter 2023 earnings released: EPS: JP¥10.72 (vs JP¥5.37 in 2Q 2022)

Mebuki Financial Group,Inc. (TSE:7167) announces an Equity Buyback for 20,000,000 shares, representing 1.85% for ¥5,000 million.

Now 20% undervalued

Mebuki Financial Group, Inc. to Report Q2, 2023 Results on Nov 11, 2022

Price target increased to JP¥293

Upcoming dividend of JP¥5.50 per share

First quarter 2023 earnings released: EPS: JP¥14.22 (vs JP¥16.63 in 1Q 2022)

Mebuki Financial Group, Inc. Provides Consolidated Earnings Guidance for Six Months Ending September 30, 2022 and Fiscal Year Ending March 31, 2023

Mebuki Financial Group, Inc. to Report Q1, 2023 Results on Aug 04, 2022

Full year 2022 earnings: EPS misses analyst expectations

Mebuki Financial Group, Inc. Provides Consolidated Earnings Guidance for the First Half Ending September 30, 2022 and Full Year Ending March 31, 2023

Mebuki Financial Group, Inc., Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

Mebuki Financial Group, Inc. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥5.50 per share

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Mebuki Financial Group, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022

Second quarter 2022 earnings released: EPS JP¥11.08 (vs JP¥7.35 in 2Q 2021)

Upcoming dividend of JP¥5.50 per share

First quarter 2022 earnings released: EPS JP¥16.63 (vs JP¥11.29 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥31.45 (vs JP¥31.14 in FY 2020)

Upcoming dividend of JP¥5.50 per share

Third quarter 2021 earnings released: EPS JP¥6.79 (vs JP¥11.04 in 3Q 2020)

Mebuki Financial Group, Inc.(TSE:8333) dropped from S&P Japan Mid Cap 100

New 90-day low: JP¥200

Mebuki Financial Group, Inc. to Report Q3, 2021 Results on Feb 05, 2021

New 90-day low: JP¥203

Mebuki Financial Group, Inc. to Report Q2, 2021 Results on Nov 09, 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse financiële instellingen